Form 4 for SMMT Summit Therapeutics Inc.
Accepted 2023-12-13 00:00:00 ET · period of report 2023-12-11 · accession 0001599298-23-000103 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2023-12-13 | 2023-12-11 | SMMT | Zanganeh Mahkam | CEO, Dir | X - OptEx | $1.58 | +315.7K | 24.89M | +1% | +$498.8K |
| D | 2023-12-13 | 2023-12-12 | SMMT | Zanganeh Mahkam | CEO, Dir | P - Purchase | $2.07 | +5,000 | 494.8K | +1% | +$10.3K |
| D | 2023-12-13 | 2023-12-11 | SMMT | Zanganeh Mahkam | CEO, Dir | X - OptEx | $1.44 | +489.8K | 489.8K | New | +$705.3K |
| DI | 2023-12-13 | 2023-12-11 | SMMT | Zanganeh Mahkam | CEO, Dir | X - OptEx | $0.00 | -315.7K | 0 | -100% | $0 |
| D | 2023-12-13 | 2023-12-11 | SMMT | Zanganeh Mahkam | CEO, Dir | X - OptEx | $0.00 | -489.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-11 | X | A | 315,681 | $1.58 | 24,889,479 | I | — | — | (F1) The Reporting Person exercised certain warrants to purchase shares of common stock in accordance with the terms of such warrants. (F3) The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
| 2 | Common | Common Stock | 2023-12-12 | P | A | 5,000 | $2.07 | 494,814 | D | — | — | (F2) The Reporting Person purchased these shares in a single transaction on the open market. |
| 3 | Common | Common Stock | 2023-12-11 | X | A | 489,814 | $1.44 | 489,814 | D By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee | — | — | (F1) The Reporting Person exercised certain warrants to purchase shares of common stock in accordance with the terms of such warrants. |
| 4 | Derivative | Warrant (right to buy) | 2023-12-11 | X | D | 315,681 | $0.00 | 0 | I | $1.58 · 2023-12-11 to 2029-12-24 | 315,681 Common Stock | (F1) The Reporting Person exercised certain warrants to purchase shares of common stock in accordance with the terms of such warrants. |
| 5 | Derivative | Warrant (right to buy) | 2023-12-11 | X | D | 489,814 | $0.00 | 0 | D By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee | $1.44 · 2023-12-11 to 2025-06-30 | 489,814 Common Stock | (F1) The Reporting Person exercised certain warrants to purchase shares of common stock in accordance with the terms of such warrants. |